A rare case of flecainide-induced encephalopathy
- PMID: 38496743
- PMCID: PMC10943541
- DOI: 10.1016/j.hrcr.2023.12.008
A rare case of flecainide-induced encephalopathy
Keywords: Antiarrhythmic drugs; Cytochrome P450; Drug-drug interaction; Encephalopathy; Flecainide.
Conflict of interest statement
The authors have no conflicts to disclose.
Similar articles
-
[Use of Pharmacogenetic Information for Therapeutic Drug Monitoring of an Antiarrhythmic Drug].Yakugaku Zasshi. 2018;138(9):1145-1150. doi: 10.1248/yakushi.18-00114. Yakugaku Zasshi. 2018. PMID: 30175758 Review. Japanese.
-
Predicting mortality after myocardial infarction from the response of RR variability to antiarrhythmic drug therapy.J Am Coll Cardiol. 1994 Mar 1;23(3):733-40. doi: 10.1016/0735-1097(94)90761-7. J Am Coll Cardiol. 1994. PMID: 7509355 Clinical Trial.
-
Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia.Circ Arrhythm Electrophysiol. 2011 Apr;4(2):128-35. doi: 10.1161/CIRCEP.110.959916. Epub 2011 Jan 26. Circ Arrhythm Electrophysiol. 2011. PMID: 21270101 Free PMC article.
-
Case report: Use of therapeutic drug monitoring and pharmacogenetic testing as opportunities to individualize care in a case of flecainide toxicity after fetal supraventricular tachycardia.Front Pediatr. 2023 Jun 28;11:1168619. doi: 10.3389/fped.2023.1168619. eCollection 2023. Front Pediatr. 2023. PMID: 37449265 Free PMC article.
-
Oral antiarrhythmic drugs in converting recent onset atrial fibrillation.Pharm World Sci. 2004 Apr;26(2):66-78. doi: 10.1023/b:phar.0000018593.02291.c0. Pharm World Sci. 2004. PMID: 15085940 Review.
Cited by
-
Early Recognition and Management of Flecainide Toxicity: A Case Report and Literature Review.Cureus. 2024 Nov 14;16(11):e73683. doi: 10.7759/cureus.73683. eCollection 2024 Nov. Cureus. 2024. PMID: 39552737 Free PMC article.
References
-
- Lynch T., Price A. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am Fam Physician. 2007;76:391–396. - PubMed
-
- Roden D. Principles in pharmacogenetics. Epilepsia. 2008;42:44–48. - PubMed
-
- Ghika J., Goy J.J., Naegeli C., Regli F. Acute reversible ataxo-myoclonic encephalopathy with flecainide therapy. Schweiz Arch Neurol Psychiatr. 1994;145:4–6. - PubMed
Publication types
LinkOut - more resources
Full Text Sources